Table 3.
Salvage regimen | |
---|---|
Brentuximab/bendamustine | 26 (39%) |
Brentuximab/gemcitabine | 15 (22%) |
Gemcitabine/vinorelbine | 10 (15%) |
Ifosfamide/vinorelbine | 9 (13%) |
Brentuximab | 8 (12%) |
Ifosfamide/carboplatin/etoposide | 6 (9%) |
Ifosfamide/gemcitabine/vinorelbine | 4 (6%) |
Brentuximab/nivolumab | 4 (6%) |
Gemcitabine/vinblastine/liposomal doxorubicin | 1 (1%) |
Bendamustine/gemcitabine/vinorelbine | 1 (1%) |
Other | 6 (9%) |